Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule featuring an indole and triazine core structure. It is classified as a triazine derivative and contains both an indole moiety and a benzonitrile group. The unique chemical structure suggests potential applications in pharmaceutical development, biomedical research, or as a diagnostic tool. However, there are no approved indications or clinical trials for this compound to date. Its mechanism of action has not been established in the literature or regulatory databases; it remains experimental with no known therapeutic use.[1][2][3][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-[4-amino-6-(5-chloro-1H-indol-4-ylmethyl)-[1,3,5]triazin-2-ylamino]-benzonitrile.